Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

KNSA — Kiniksa Pharmaceuticals International, plc

EXPENSIVE (MOS -157.1%) · Quality 79/100

KNSA - Kiniksa Pharmaceuticals International, plc
Data generated 2026-09-19 21:53 UTC (nightly scan, universe: Russell 3000).
Price: 77.24 USD
Intrinsic value: 30.04 USD
Margin of safety: -157.1%
Implied growth (reverse DCF): +28.6% (model assumes +16.0%)
Valuation: EXPENSIVE
Value Score: 17.8
Quality: 79/100
Moat score: 30 (erosion: watch)
EXPENSIVE (MOS -157.1%) - Quality 79/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/KNSA
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

77.24

Intrinsic value

30.04

Margin of safety

-157.1%

Implied growth (reverse DCF)

+28.6%

model assumes +16.0%

Value Score

17.8

Quality

Psychology

-4.7

Discovery

15.4

price/volume attention only

Moat score

erosion: watch

Value Score: bottom 27% of Russell 3000 · Quality: top 5%

Open the interactive Deep Dive for KNSA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/KNSA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is KNSA undervalued?

As of 2026-09-19, KNSA trades at 77.24 against a computed intrinsic value of 30.04 (-157.1% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Kiniksa Pharmaceuticals International, plc's Value Score?

Kiniksa Pharmaceuticals International, plc's Value Score is 17.8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.